Fibrinogen and CRP in Israeli families: Genetic and environmental sources of concentrations and longitudinal changes

Atherosclerosis

Volumn 189, Issue 1, 2006, Pages 169-177

  Friedlander, Yechiel ^a   Kark, Jeremy D ^a   Sinnreich, Ronit ^a   Tracy, Russell P ^b   Siscovick, David S ^c,d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b UNIVERSITY OF VERMONT   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CRP; Environment; Fibrinogen; Genetics; Interactions

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENE LOCUS; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; ISRAEL; MALE; MOLECULAR PHYLOGENY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL ILLNESS; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; ISRAEL; MALE; MIDDLE AGED; PHENOTYPE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33748965319     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.11.030     Document Type: Article

References (38)

1. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemostasis 89 (2003) 601-609
2. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality. An individual participant meta-analysis. JAMA 294 (2005) 1799-1809
3. Shah S.H., and Newby L.K. C-reactive protein: a novel marker of cardiovascular risk. Cardiol Rev 11 (2003) 169-179
4. Koenig W. Update on C-reactive protein as a risk marker in cardiovascular disease. Kidney Int 84 Suppl (2003) S58-S61
5. Meade T.W., Imeson J., and Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease. Lancet 2 (1987) 986-988
6. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 312 (1996) 1061-1065
7. Markowe H.L.J., Maromot M.G., Shipley M.G., et al. Fibrinogen: a possible link between social class and coronary heart disease. Br Med J 291 (1985) 1312-1314
8. Pankow J.S., Folsom A.R., Cushman M., et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154 (2001) 681-689
9. Livshits G., Schettler G., Graff E., et al. Tel Aviv-Heidelberg three-generation offspring study: genetic determinants of plasma fibrinogen level. Am J Med Genet 63 (1996) 509-517
10. Pankow J.S., Folsom A.R., Province M.A., et al. Segregation analysis of plasminogen activator inhibitor-1 and fibrinogen levels in the NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 18 (1998) 1559-1567
11. Perusse L., Moll P.P., and Sing C.F. Evidence that a single gene with gender- and age-dependent effects influences systolic blood pressure determination in a population-based sample. Am J Hum Genet 49 (1991) 94-105
12. Borecki I.B., Bonney G.E., Rice T., Bouchard C., and Rao D.C. Influence of genotype-dependent effects of covariates on the outcome of segregation analysis of the body mass index. Am J Hum Genet 53 (1993) 676-687
13. Friedlander Y., Elkana Y., Sinnreich R., and Kark J.D. Genetic and environmental sources of fibrinogen variability in Israeli families: the Kibbutzim Family Study. Am J Hum Genet 56 (1995) 1-13
14. Lalouel J.M., Rao D.C., Morton N.E., and Elston R.C. A unified model for complex segregation analysis. Am J Hum Genet 35 (1983) 816-826
15. Hasstedt S.J. PAP: pedigree analysis package, Revision 4.0 (1994), Department of Human Genetics, University of Utah, Salt Lake City
16. Demenais F., Lathrop M., and Lalouel J.M. Robustness and power of the unified model in the analysis of quantitative measurements. Am J Hum Genet 38 (1986) 228-234
17. Akaike H. A new look at the statistical model identification. IEE Trans Automat Contr 19 (1974) 716-723
18. Almasy L., and Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62 (1998) 1198-1211
19. Towne B., Siervogel R.M., and Blangero J. Effects of genotype-by-sex interaction on quantitative trait linkage analysis. Genet Epidemiol 14 (1997) 1053-1058
20. Self S.G., and Liang K.Y. Asymptotic properties of maximum likelihood estimators and likelihood ratio tests under non-standard conditions. J Am Statist Assoc 82 (1987) 605-610
21. Retterstol L., Eikvar L., and Berg K. A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169 (2003) 279-282
22. Lange L.A., Langefeld C.D., Beck S.R., et al. Familial aggregation of C-reactive protein in type 2 diabetes. Circulation 107 (2003) 22
23. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc 282 (1999) 2131-2135
24. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 82 (1997) 4196-4200
25. Humphries S.E., Green F.R., Thomas A.E., Kelleher C.H., and Meade T.W. Genetic control of plasma fibrinogen levels: an example of gene-environment interaction in the etiology of a multifactorial disorders. In: Lindsten J., and Pettersson U. (Eds). Etiology of human disease at the DNA level (1991), Raven Press 115-128
26. Vaisanen S., Rauramaa R., Pentilla I., et al. Variation in plasma fibrinogen over one year: relationships with genetic polymorphisms and non-genetic factors. Thromb Haemostasis 77 (1997) 884-889
27. de Maat M.P.M., de Bart A.C.W., Hennis B.C., et al. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arteriosclerosis Thrombosis Vasc Biol 16 (1996) 1156-1162
28. Humphries S.E., Luong L.-A., Montgomery H.E., et al. Gene-environment interaction in the determination of levels of plasma fibrinogen. Thromb Haemostasis 82 (1999) 818-825
29. -455-A beta-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 15 (1995) 96-104
30. Tappia P.S., Troughton K.L., Langley-Evans S.C., and Grimble R.F. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci 88 (1995) 485-489
31. Vischetti M., Zito F., Donati M.B., and Iacoviello L. Analysis of gene-environment interaction in coronary heart disease: fibrinogen polymorphisms as an example. Int Heart J 3 (2002) 18-23
32. Ardissino D., Mannucci P.M., Merlini P.A., et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 94 (1999) 46-51
33. Barakat K., Kennon S., Hitman G.A., et al. Interaction between smoking and the glycoprotein IIIa P1A2 polymorphism in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol 38 (2001) 1639-1643
34. Fishman D., Faulds G., Jeffery R., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
35. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
36. Reiner A.P., Diehr P., Browner W.S., et al. Common promoter polymorphisms of inflammation and thrombosis genes and longevity in older adults: the cardiovascular health study. Atherosclerosis 181 (2005) 175-183
37. Giacconi R., Cipriano C., Albanese F., et al. The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol 39 (2004) 621-628
38. Jones K.G., Brull D.J., Brown L.C., et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265